drugset / Trial / NCT03729128

Add-on Low Dose Dextromethorphan and Memantine in Patients With Amphetamine-type Stimulants Use Disorder

NCT03729128

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The current study will investigate whether add-on dextromethorphan (DM) and memantine (MM) is able to improve the treatment outcomes for ATSUD, and be associated with improvement in inflammatory markers, neurotrophic factors and neuropsychological tests.

Timeline

Start
2018-07-24
Primary completion
2020-08-31
Completion
2020-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Dextromethorphan Unknown 30 mg
Subject Memantine Unknown 5 mg